Dupliyuzumab, typically the first dose is injected in two separate injections at different sites.
Duplizumab is a targeted therapy drug that is used to treat moderate to severe adult atopic dermatitis.
The recommended first dose for adults is 600 mg administered by two subcutaneous injections in different parts of the body, such as the inner and outer thighs, the abdominal wall, except for the area up to 5 cm around the navel. If the injection is given by another person, it may also be given in the upper arm.
Follow-up treatment (every two weeks) is usually a single injection of 300mg without further separation, and it is recommended that the injection site is rotated with each injection. It should not be injected into fragile, damaged or bruised or scarred skin.
Adverse reactions to Dupliyuzumab mainly include infections, skin irritation reactions, etc. It needs to be contraindicated for those who are allergic to the drug components.
In order to ensure the safety and effectiveness of the medication, it is important to use the medication in strict accordance with the doctor’s instructions.